Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 678-681
- https://doi.org/10.1016/0959-8049(94)00497-s
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Paclitaxel (Taxol) induces cumulative mild neurotoxicityEuropean Journal Of Cancer, 1994
- Large and small fibre type sensory dysfunction in patients with cancer.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicityJournal of the Neurological Sciences, 1989
- Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose RegimenJNCI Journal of the National Cancer Institute, 1989
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- Cis-diamminedichloroplatinum (II) by 5-day continuous infusion a new dose schedule with minimal toxicityCancer, 1984
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981
- Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- THE NEUROMUSCULAR FUNCTION IN PATIENTS WITH MALIGNANT TUMOURSBrain, 1967